First-line (1L) ribociclib (RIB) plus endocrine therapy (ET) vs combination chemotherapy (combo CT) in clinically aggressive hormone receptor (HR)+/HER2-advanced breast cancer (ABC): A subgroup analysis of patients (pts) with or without liver metastases (mets) from RIGHT Choice.

El Saghir N. S., Im S., Azim H. A., Eralp Y., Yap Y. S., Sandhu M. S., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.43, no.16_SUPPL, 2025 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 43 Issue: 16_SUPPL
• Publication Date: 2025
• Doi Number: 10.1200/jco.2025.43.16_suppl.1069
• Journal Name: JOURNAL OF CLINICAL ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Nature Index
• Acibadem Mehmet Ali Aydinlar University Affiliated: No